Page 17 - 2021 Taiwan Food and Drug Administration Annual Report

Act” FRQWUROOHG GUXJV DUH FDWHJRUL]HG LQWR Section 5

four categories: their potential for habitual Overview of Medical
XVH GHSHQGHQFH DEXVH DQG GDQJHU WR VR- Devices and Cosmetics
Management
ciety. The source management of various
W\SHV RI XVHUV VXFK DV LQVWLWXWLRQV LQGXVWU\ I. Medical devices management
RSHUDWRUV SK\VLFLDQV GHQWLVWV YHWHULQDUL- framework
DQV RU SDUDYHWHULQDU\ ZRUNHUV LV FRQGXFWHG
WKURXJK FHUWL¿FDWLRQV VXFK DV FRQWUROOHG GUXJ Following technological advancement
UHJLVWUDWLRQ FHUWLILFDWH XVH OLFHQVH DQG H[- and increasing demand for technological
SRUW LPSRUW DQG PDQXIDFWXULQJ DJUHHPHQW PHGLFDO DQG KHDOWK GHYLFHV WKH PHGLFDO GH-
7KH IORZ PDQDJHPHQW LV DOVR VWUHQJWKHQHG vice industry has become one of the most
promising industries in the biotechnology
requiring users to register and declare the sector in Taiwan. In response to the booming
LQFRPH H[SHQVH DQG EDODQFH RI FRQWUROOHG development of domestic medical device
GUXJV LQ OHGJHUV WR SUHYHQW WKH XVH RU DEXVH LQGXVWU\ 7)'$ KDV HVWDEOLVKHG D TXDOLW\

of controlled drugs. Its management struc-

ture is shown in Figure 1-6.

Registration Reporting Inspection • Registration certificate of
controlled drug
Institutions Health authorities
(institutions, business operators)
Diversion Licensing
management system • License of controlled drug

Schedule [dentists, physicians, and veterinarian]
management
• Permit for exporting, importing
and manufacturing

(Source management)

• Relevant license: transportation
permit, letter of approval for
medical education, research,
and trial

Four schedules of management
according to addictiveness,
dependence, abuse, and social
risks. Schedule 1 is relatively
risky.

Figure1-6 Management structure of controlled drugs

15